The most effective natural Osteoarthritis treatment
Click on a box to see what we consider
the most effective natural Osteoarthritis treatment for you

WOMEN 39
AND UNDER		 MEN 39
AND UNDER		 WOMEN 40
AND UP		 MEN 40
AND UP
click here...click here...click here...click here...

What is Osteoarthritis?

Osteoarthritis is inflammation of one or more joints, which results in pain, swelling, stiffness and limited movement. It involves the breakdown of cartilage and usually occurs when the rebuilding of cartilage has difficulty keeping up with the wear and tear on joints. This can be due to, among other things, deficiency of basic essential nutrients (like certain vitamins and minerals) and deficiency of natural anti-inflammatory substances often worsened by increasing age or extreme physical activity (competitive sports). When the rebuilding of cartilage cannot keep up with the deterioration of cartilage, inflammation follows, which in turn reinforces the negative progression of osteoarthritis.

To avoid wear and tear, it is therefore important to supply the body with sufficient amounts of basic nutrients and specific anti-inflammatory nutritional supplements that the body can no longer produce in sufficient amounts, such as chondroitin and glucosamine.

Which natural ingredients can have an effect on osteoarthritis?

Chondroitin sulfate, glucosamine sulfate, methylsulfonylmethane (MSM), ginger root extract, copper, magnesium, manganese, molybdenum, selenium, zinc, vitamins A, B6, B2, E, C, D3 and B9 (folic acid), grape seed extract, fish oils (EPA/DHA) and more.

What effects do these ingredients have?

  • Long-term effect, unlike NSAIDs (non-steroidal anti-inflammatory drugs). According to a recent double-blind study, the combination of glucosamine and chondroitin is a more effective painkiller than NSAIDs (like Ibuprofen etc.) for moderate to severe myofascial pain, the most common form of pain. The maximum pain-killing effect is seen within four to five days of treatment.
  • Rebuild cartilage, unlike NSAIDs, which according to scientific studies often break down cartilage.
  • Stimulate the growth of cartilage, unlike NSAIDs, which may inhibit growth.
  • Improve the density of cartilage, unlike NSAIDs, which may make the cartilage layer thinner.
  • Increase distance between the joint bones; in severe osteoarthritis, the distance between the joint bones is often narrowed.
  • Stop the progression of osteoarthritis.
  • Has a synergistic effect, which means faster and more pronounced effect when you combine chondroitin, glucosamine and MSM.
  • Lower the internationally known arthritic index (WOMAC).
  • Improve patients’ quality of life.
  • Glucosamine even rebuilds cartilage damaged by NSAIDs.

For the reader with a deeper interest:

How do these ingredients work?

  • Treat and prevent vitamin and mineral deficiencies.
  • Deliver the raw materials needed to produce cartilage.
  • Inhibit cyclooxygenase-2 (COX-2 inhibitors) enzymes.
  • Inhibit the breakdown of collagenase phospholipase enzymes.
  • Inhibit the inflammatory markers TNF-a and interleukin-1B.
  • Inhibit the production of leukotriene B4 and prostaglandin E2.
  • Stimulate the synthesis of proteoglycans and glycosaminoglycans that promote the rebuilding of cartilage.
  • Improve mobility of the joints.
  • Improve the viscosity of synovial fluid inside the joints.
  • Have no dangerous side effects.

The information above is based on more than 58,000 articles published in scientific journals and which are available at MEDLINE, the world's largest medical database. Below you will find a few of them listed:

References

  1. Abdel Fattah W, Hammad T. Chondroitin sulfate and glucosamine: A review of their safety profile. JANA. 2001;3:16-23.
  2. Abraham GE, Flechas JD. Management of fibromyalgia: rationale for the use of magnesium and malic acid. J Nutr Med. 1992:3:49-59.
  3. Adebowale AO, Cox DS, Liang Z, et al. Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials. J Am Nutraceutical Assoc. 2000;3:37-44.
  4. Ahmed RS, Seth V, Pasha ST, et al. Influence of Dietary Ginger (Zingiber officinales Rosc) on Oxidative Stress Induced by Malathion in Rats. Food Chem Toxicol. May2000;38(5):443-50.
  5. Ajiboye R, Harding JJ. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione. Exp Eye Res. 1989;49:31-41.
  6. Albert SG, Fishman Oiknine R, Parseghian S, et al. The effect of glucosamine on serum high density lipoprotein cholesterol and apolipoprotein AI levels in people with diabetes mellitus. Diabetes Care. 2007 Aug 6. [Epub ahead of print]
  7. Alexander JW. Immunonutrition: the role of omega-3 fatty acids.Nutr 1998;14:627–33.
  8. Alfano AP, Taylor AG, Foresman PA, et al. Static magnetic fields for treatment of fibromyalgia: a randomized controlled trial. J Altern Complement Med. 2001;7:53-64.
  9. Ali M, Afzal M, Gubler CJ, Burka JF. A potent thromboxane formation inhibitor in green tea leaves.Prostaglandins Leukot Essent Fatty Acids 40:281-283; 1990.
  10. Ali M, et al. A Potent Inhibitor of Thrombin Stimulated Platelet Thromboxane Formation from Unprocessed Tea. Prostaglandins Leukot Med. Apr1987;27(1):9-13.
  11. Alizadeh-Navaei R, Roozbeh F, Saravi M, et al. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J. 2008;29:1280-1284.
  12. Almada AL, Harvey PW, Platt KJ. Effect of chronic oral glucosamine sulfate upon fasting insulin resistance index (FIRI) in nondiabetic individuals [abstract]. FASEB J. 2000;14:A750.
  13. Almallah YZ, El-Tahir A, Heys SD, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 2000;30:58–65.
  14. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. Nov2001;44(11):2531-8.***
  15. Anderson JW, Nicolosi RJ, Borzelleca JF, et al. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2004;43:187-201.
  16. Bliddal H, Rosetzsky A, Schlichting P, et al. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage. 2000;8:9-12.
  17. Boss PK, et al. Expression of Anthocyanin Biosynthesis Pathway Genes in Red and White Grapes. Plant Mol Biol. 1996;32(3):565-69.
  18. Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. Osteoarthritis Cartilage. 1998;6(suppl A):25-30.
  19. Braham R & al. The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med, 37(1): 45-9; discussion 49 2003.
  20. Brooks PM, Potter SR, Buchanan WW. NSAID and osteoarthritis—help or hindrance? J Rheumatol. 1982;9:3-5.
  21. Brown KE, Leong K, Huang C, et al. Gelatin/Chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint. Arthritis and Rheum. 1998;41(12):2185-2195.
  22. Bruyere O, Pavelka K, Rovati LC, et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause. 2004;11:138-143.
  23. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage. 2007 Jul 26. [Epub ahead of print]
  24. Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage. 1998;6(suppl A):31-36.
  25. Chavez ML. Glucosamine sulfate and Chondroitin sulfats. Hosp Pharm. 1997;32(9):1275-1285.
  26. Cohen M, Wolfe R, Mai T, et al. A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol. 2003;30:523-528.
  27. Conrozier T. Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6) [translated from French]. Presse Med. 1998;27:1862-1865.
  28. ConsumerLab.com 2001a. Product review: glucosamine and Chondroitin.. Accessed May 24, 2001.
  29. Crolle G, D'Este E. Glucosamine sulfate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin. 1980;7:104-109.
  30. Das A Jr and Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage. 2000;8:343-350.
  31. Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin Ther. 1980;3:260-272.
  32. Gaby AR. Natural treatments for osteoarthritis. Altern Med Rev. 1999;4(5):330-341.
  33. Hellio MP. The effects of glucosamine on human osteoarthritic chondrocytes. In vitro investigations. Presented at: The Ninth EULAR Symposium; October 7-10, 1996; Madrid, Spain.
  34. Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007 Jan 30. [Epub ahead of print]
  35. Holtmann S, Clarke AH, Scherer H, et al. The anti-motion sickness mechanism of ginger. Acta Otolaryngol. 1989;108:168-174.
  36. Houpt JB, McMillan R, Wein C, et al. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol. 1999;26:2423-2430.
  37. Hughes R, Carr A. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology (Oxford). 2002;41:279-284.
  38. Jimenez SA. The effects of glucosamine on human chondrocyte gene expression. Presented at: The Ninth EULAR Symposium; October 7-10, 1996; Madrid, Spain.
  39. Kim LS, Axelrod LJ, Howard P et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. 2005 Nov 22. [Epub ahead of print]
  40. Lawrence RM. Methyl-sulfonyl-methane (MSM). A double-blind study of its use in degenerative arthritis. Unpublished correspondence.
  41. McAlindon T, Formica M, LaValley M, et al. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am J Med. 2004;117:643-649.
  42. McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000;283:1469-1475.
  43. Messier SP, Mihalko S, Loeser RF, et al. Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study. Osteoarthritis Cartilage. 2007 Jun 8. [Epub ahead of print]
  44. Morreale P, Manopulo R, Galati M, et al. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol. 1996;23:1385-1391.
  45. Murav'ev IuV, Venikova MS, Pleskovskaia GN, et al. Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis [in Russian]. Patol Fiziol Eksp Ter. 1991;2:37-39.
  46. Nakamura H, Masuko K, Yudoh K, et al. Effects of glucosamine administration on patients with rheumatoid arthritis. Rheumatol Int. 2006 Sep 5. [Epub ahead of print]
  47. Noack W, Fischer M, Forster KK, et al. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage. 1994;2:51-59.
  48. Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002;162:2113-2123.
  49. Qiu GX, Weng XS, Zhang K, et al. A multi-central, randomized, controlled clinical trial of glucosamine hydrochloride/sulfate in the treatment of knee osteoarthritis. Zhonghua Yi Xue Za Zhi. 2005;85:3067-3070.
  50. Reichenbach S, Sterchi R, Scherer M, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007;146:580-590.
  51. Richy F, Bruyere O, Ethgen O, et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003;163:1514-1522.
  52. Rovati LC. A large, randomized, placebo controlled, double-blind study of glucosamine sulfate vs. piroxicam and vs. their association, on the kinetics of the symptomatic effect in knee osteoarthritis. Osteoarthritis Cartilage. 1994;2(suppl 1):56.
  53. Rovati LC. The practical development of a selective drug for osteoarthritis: glucosamine sulfate. Presented at: The Ninth EULAR Symposium; October 7-10, 1996; Madrid, Spain.
  54. Rozendaal RM, Koes BW, van Osch GJ, et al. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med. 2008;148:268-277.
  55. Setnikar I, Pacini MA, Revel L. Antiarthritic effects of glucosamine sulfate studied in animal models. Arzneimittelforschung. 1991;41:542-545.
  56. Shield MJ. Anti-inflammatory drugs and their effects on cartilage synthesis and renal function. Eur J Rheumatol Inflamm. 1993;13:7-16.
  57. Uebelhart D, Malaise M, Marcolongo R, et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage. 2004;12:269-276.
  58. Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage. 1998;6(suppl A):39-46.
  59. Usha P.R., Naidu M.U.R. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Investigation. 2004;24:353-363.
  60. Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage. 1998;6(suppl A):37-38.
  61. Vlad SC, Lavalley MP, McAlindon TE, et al. Glucosamine for pain in osteoarthritis: Why do trial results differ? Arthritis Rheum. 2007 Jun 28. [Epub ahead of print]
  62. Wigler I, Grotto I, Caspi D, Yaron M. The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarthritis Cartilage. 2003;11:783-789.